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Abstract
Background: Adenoid basal carcinoma of the cervix is a rare condition mostly occurring among
postmenopausal women. Although it can be confused with adenoid cystic carcinoma of the cervix,
adenoid basal carcinoma has several clinicopathologic features that will allow distinction from
adenoid cystic carcinoma.
Case presentation: This is the case of a twenty-year old African-American female who initially
presented with a high-grade squamous intraepithelial lesion on Pap smear, with a subsequent
cervical LEEP specimen revealing adenoid basal carcinoma. The lesion showed the characteristic
histologic features of adenoid basal carcinoma and was positive for the immunohistochemical
marker EMA and negative for collagen IV, further defining the tumor while helping to rule out the
possibility of adenoid cystic carcinoma. As far as the authors are aware, this is the youngest
reported case of adenoid basal carcinoma to date.
Conclusion: This case shows that adenoid basal carcinoma can deviate markedly from its typical
postmenopausal demographics to affect women as young as 20 years of age. In addition, adenoid
basal carcinoma has several identifiable features that will differentiate it from adenoid cystic
carcinoma including histologic and cellular morphologies, as well as immunohistochemistry.
Treatment for most patients involves hysterectomy, LEEP, or a conization procedure which
provides a favorable prognosis because of this lesion's low potential for recurrence and metastasis.
Background
Adenoid basal carcinoma (ABC) of the cervix is a rare neo-
plasm with a predilection for postmenopausal non-Cau-
casian women. It accounts for less than 1% of all cervical
adenocarcinomas. Since its original recognition in 1966
by Baggish and Woodruff [1,2], there have been fewer
than 100 reported cases of this condition (90 as of this
writing), with the vast majority occurring among women
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45 years of age or older. However, Zamecnik [3] recently
reported a case occurring in a 21 year-old female. Herein,
we present the occurrence of ABC within the uterine cervix
of a 20-year-old female, the youngest reported case of its
kind and only the second reported case in a patient
younger than thirty years of age.
Case presentation
A 20-year-old African American female presented with a
history of a high-grade squamous intraepithelial lesion
(HSIL) on Pap smear. A colposcopy was performed and
yielded three cervical biopsies and an endocervical curet-
tage, all of which showed no significant pathologic altera-
tion with exception of one cervical biopsy that showed
HPV-effect. Still concerned with the patient's HSIL result,
clinicians performed a cervical loop electrosurgical exci-
sion procedure (LEEP), during which multiple erosions of
inflammation were observed to be overlying the cervix.
Materials and methods
5-um sections from the formalin-fixed, paraffin-embed-
ded tissue were used for routine light microscopic study as
well as immunohistochemical analysis including the anti-
bodies against prostate-specific antigen (PSA) (1:100),
epithelial membrane antigen (EMA) (prediluted), and
collagen IV (1:40) (DakoCytomation, Glostrup, Den-
mark). These immunohistochemical stains were per-
formed by a labeled avidin-biotin complex
immunoperoxidase method using commercially available
monoclonal antibodies and DAB as the chromogen. In
order to provide negative controls on patient tissue and
thereby ensure specificity of the reactions, the aforemen-
tioned antibodies were substituted for an unrelated anti-
body during the incubation procedure. Formalin-fixed
and paraffin-embedded tissue from kidney, prostate, and
breast were used as positive controls for collagen IV, PSA,
and EMA, respectively.
Pathologic findings
The gross LEEP specimen measured 1.3 cm in diameter
and 0.4 cm in depth. The cervical mucosa was purple-tan,
smooth and glistening. No demonstrable lesions were
present.
Microscopically, hematoxylin- and eosin-stained sections
showed cervical stroma involved by scattered cellular pro-
liferations arranged in nests with a striking peripheral pal-
isading arrangement (Fig. 1) and microcyst formation. A
stromal reaction to these nests was not present (Fig. 2).
The cells were uniform, round to oval, and had scant cyto-
plasm. Nuclei were hyperchromatic, showing inconspicu-
ous nucleoli and minimal nuclear atypia. Mitotic figures
were not identified. The squamous epithelium showed
occasional, sporadic foci of lymphocytic infiltration not
necessarily coincident to the underlying tumor nests.
Definitive squamous intraepithelial lesions were not
present.
In order to further elucidate the nature of the tumor,
immunohistochemical stains were performed. A stain for
EMA showed strong, diffuse cellular membrane staining
of the tumor cells (Fig. 3), whereas stains for PSA and col-
lagen IV did not highlight cells from the lesion. The posi-
tive control tissues were diffusely and strongly positive for
their respective antibodies.
(H&E, ×10): The cervical stroma shows scattered cellular  proliferations arranged in nests with peripheral palisading and  microcyst formation Figure 2
(H&E, ×10): The cervical stroma shows scattered cellular 
proliferations arranged in nests with peripheral palisading and 
microcyst formation. A stromal reaction to these nests is 
absent.
(H&E, ×100): A palisading arrangement around the periph- ery of this cellular nest is striking Figure 1
(H&E, ×100): A palisading arrangement around the periph-
ery of this cellular nest is striking.Diagnostic Pathology 2006, 1:20 http://www.diagnosticpathology.org/content/1/1/20
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Comment
Adenoid basal carcinoma is a rare, indolent lesion of the
uterine cervix most commonly occurring in postmeno-
pausal African-American females, although some recent
reports have shown that these tumors can also occur in
Asian patients [4-6]. Its cellular origin remains uncertain,
but immunohistochemical evidence has shown that this
lesion may originate from the reserve cell layer of the cer-
vical epithelium [7].
Cviko [8] enumerated the four distinct components of
ABC: a classic HSIL; a limited invasive component with
squamoid maturation, often with a discrete layer of
peripheral basal cells; an outgrowth of small basal cells
from either HSIL or squamoid areas; and focal endocervi-
cal (adenoid) differentiation.
Histologically, ABC has been described as a proliferation
of nested uniform, bland basaloid cells with a peripheral
palisading pattern. Mild chromatin abnormalities are
present with small nucleoli and rare mitoses. Cytologi-
cally, the neoplasm appears as discohesive groups of
intact cells with overlapping nuclei, moderately high
nuclear-to-cytoplasm ratio, occasional peripheral palisad-
ing, finely granular chromatin, mild hyperchromasia, and
small nucleoli [9].
Immunohistochemical characteristics include stain posi-
tivity for CK14, CK17, CK19 [3] and Cytokeratin KL 1 [9].
Of the nine cases of ABC studied by Grayson [10], all were
positive for EMA but totally negative for collagen IV and
laminin, compared to adenoid cystic carcinoma (ACC)
which was positive for all three stains. Unfortunately, we
were unable to perform a laminin stain on the tissue for
this case, but the fact that collagen IV alone did not high-
light any of the tumor cells (and again taking into consid-
eration the architectural and cytologic features of the
tumor) provides solid evidence that this lesion is indeed
adenoid basal carcinoma, and not ACC.
Genetic studies have shown correlation with viral infec-
tion. Takeshima [6] correlated the occurrence of ABC to
human papilloma virus infection. Jones [11] character-
ized the presence of HPV type 16 among the five cases he
studied. Moreover, p53 gene alterations including wild
type hyperexpression and p53 point mutational damage
were noted. Our patient showed HPV-effect on a cervical
biopsy, but the LEEP specimen revealed neither HPV
changes nor squamous intraepithelial lesions.
The overwhelming majority of cases are benign owing to
the low potential for recurrence and metastasis. This has
led to an alternative designation, adenoid basal epitheli-
oma. Brainard [12] and colleagues, in their review of 12
cases, pointed out that adenoid basal carcinoma with typ-
ical features is not a malignant neoplasm, does not pro-
duce a visible lesion, does not metastasize, and never itself
has caused death. Thus, they proposed that the name be
changed to reflect the neoplasm's benignity.
Because of its favorable prognosis, this lesion should be
distinguished from more malignant processes such as
ACC, which carries a recurrent and metastatic potential;
adenoma malignum (minimal deviation adenocarci-
noma); and mesonephric adenocarcinoma. The most
important of these to consider is ACC, which histologi-
cally can appear very similar to ABC. Furthermore, they
both show positive reactivity to CEA, EMA, CK7, CK20,
and CAM 5.2 [10]. However, cellular pleomorphism,
mitoses, necrosis, stromal hyalinization, and metastasis
are commonly identified in ACC but are rare or absent in
ABC. Moreover, as previously discussed, immunohisto-
chemical studies show positive reactivity to collagen IV
and laminin for ACC whereas these stains do not high-
light the tumor cells of ABC [10].
Other entities to consider within the differential diagnosis
include small cell carcinoma of the cervix, carcinoid
tumor of the cervix, carcinosarcoma of the cervix, and
ectopic prostatic tissue. The last of these was ruled out in
our case by using a PSA immunohistochemical marker.
Again, histologic, morphologic, and immunohistochemi-
cal characteristics of ABC should distinguish it from these
other entities.
(EMA, ×40): Most of the tumor cells within the nests show  a strong, diffuse cellular membrane staining Figure 3
(EMA, ×40): Most of the tumor cells within the nests show 
a strong, diffuse cellular membrane staining. The peripheral 
palisading cells show a uniform lack of reactivity to the anti-
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Conclusion
This tumor represents the youngest reported occurrence of
adenoid basal carcinoma of the cervix. This case, along
with that reported by Zamecnik [3], shows that ABC may
not always conform to its usual demographics, affecting
women as young as their early twenties. Clinicians and
pathologists alike are thereby urged to expand their age
demographics for this cervical neoplasm.
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